EndoSphere, Inc. is a medical device company that has developed a novel device for treating one of the world’s largest and fastest-growing health epidemics: obesity and associated type 2 diabetes.
The Company’s flagship product, the SatiSphere™ System, is an elegant, non-invasive, endoscopically-delivered, temporary device that leverages the body’s natural physiology to enable safe and effective weight loss. The device is an advancement in patient comfort and tolerability during the treatment period. The SatiSphere expedites weight loss by increasing contact time between ingested food and the afferent nerves lining the walls of the duodenum, triggering the release of hormones that regulate appetite and satiety earlier and for a longer period of time. By accelerating and prolonging satiety through this natural process, the device enables treated patients to feel full sooner and longer, thereby accelerating weight-loss and a successful transition to a sustainable lifestyle modification program.
SatiSphere System under development and is not commercially available in the United States